美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

艾格里房产

74.50

-0.4300-0.57%

盘前：73.67-0.8300-1.11%09:05 EDT

成交量：108.62万

成交额：8,086.03万

市值：81.81亿

市盈率：42.12

高：74.91

开：74.82

低：73.88

收：74.93

数据加载中...

总览公司新闻公告

石药，ADC“出海”折戟

石药集团ADC创新药出海两年多被退货，数据造假还是被造谣

南方都市报

药明生物2024年业绩稳健攀升， 2025年预期加速增长

艾伯维起诉Genmab及普方生物等主体

药明合联2024年再创辉煌：业务强劲增长，财务业绩亮眼

ADC CRDMO龙头药明合联(02268)业绩“封神”：营收破40亿！暴涨90.8% 净利狂飙277%

智通财经网

【券商聚焦】中信证券：PD-L1 ADC药物兼具双重功效潜在市场规模巨大

信达生物IBI354 (创新型HER2 ADC) 治疗铂耐药卵巢癌的III期临床研究完成首例受试者给药

【中信证券：PD-L1 ADC药物有望触及全球超500亿美元IO市场】中信证券指出，PD-L1 ADC药物兼具免疫治疗药物和靶向ADC的双重功效，潜在可触及市场规模有望对标全球超过500亿美元的免疫治疗药物。多个美国市场高发的癌种PD-L1阳性率超过50%。辉瑞公司的PD-L1 ADC已经在NSCLC、HNSCC重度经治人群展现出优异疗效，并且安全性可控，辉瑞预计将在25H2启动2项三期临床，为赛道大幅增加研发确定性。国内复宏汉霖的PD-L1 ADC已经在2025年前后陆续启动5项二期临床，并且预计其有望在2025年读出一期临床数据。综上，建议关注PD-L1 ADC的临床潜力和商业化价值。

吉利德ADC单抗乳腺癌新适应症在中国获批

每日经济新闻

智元机器人提出一种全新的数据采集范式ADC 与传统范式相比，使用20%数据量达到其2.7倍的效果

视频滚动新闻

港股异动 | 康宁杰瑞制药-B(09966)涨超19% HER2双抗ADC药物JSKN003获突破性疗法认定

康宁杰瑞HER2双抗ADC药物JSKN003获突破性疗法认定，用于治疗铂耐药卵巢癌

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results

东曜药业(01875.HK)：ADC赛道出海破局者，国际质量体系能否打开利润增长极?

成都普诺科技取得一种 ADC 电路板测量辅助冶具专利，便于将多种大小电路板辅助安装且提高效率

港股异动 | 药明合联(02268)盘中涨超8% 宣布与AbTis签署战略合作意向书加速创新型ADC药物研发推进

石药集团：SYH2051获美国临床试验批准

药明合联荣膺2025“亚太生物医药卓越奖”多项殊荣

科伦博泰生物-B盘中涨超5% TROP2 ADC芦康沙妥珠单抗第二项适应症获批上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ADC/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房产","latestPrice":74.5,"timestamp":1747944000000,"preClose":74.93,"halted":0,"volume":1086157,"hourTrading":{"tag":"盘前","latestPrice":73.67,"preClose":74.5,"latestTime":"09:05 EDT","volume":34,"amount":2532.94458,"timestamp":1748005512912},"delay":0,"floatShares":107727624,"shares":109806548,"eps":1.768583,"marketStatus":"盘前交易","change":-0.43,"latestTime":"05-23 09:05:19 EDT","open":74.82,"high":74.91,"low":73.875,"amount":80860332.939762,"amplitude":0.013813,"askPrice":75.34,"askSize":1,"bidPrice":71.69,"bidSize":3,"shortable":3,"etf":0,"ttmEps":1.768583,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1748007000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":74.5,"dividendRate":0.04051,"preHourTrading":{"tag":"盘前","latestPrice":73.67,"preClose":74.5,"latestTime":"09:05 EDT","volume":34,"amount":2532.94458,"timestamp":1748005512912},"postHourTrading":{"tag":"盘后","latestPrice":74.5,"preClose":74.5,"latestTime":"17:51 EDT","volume":18559,"amount":1382642.91,"timestamp":1747950711510},"volumeRatio":1.0747974656287616,"impliedVol":0.2196,"impliedVolPercentile":0.5703},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":107727624,"roa":"2.30%","roe":"3.55%","lyrEps":1.793039,"volumeRatio":1.0747974656287616,"shares":109806548,"dividePrice":3.018,"high":74.91,"amplitude":0.013813,"preClose":74.93,"low":73.875,"week52Low":58.52,"pbRate":"1.50","psRate":"12.85","week52High":79.65,"institutionHeld":0.8991,"latestPrice":74.5,"committee":0.5,"eps":1.768583,"divideRate":0.04051,"volume":1086157,"delay":0,"ttmEps":1.768583,"open":74.82,"prevYearClose":70.45,"prevWeekClose":74.92,"prevMonthClose":77.61,"prevQuarterClose":77.19,"fiveDayClose":73.92,"twentyDayClose":76.29,"sixtyDayClose":72.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522331211","title":"石药，ADC“出海”折戟","url":"https://stock-news.laohu8.com/highlight/detail?id=2522331211","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522331211?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 17:04","pubTimestamp":1742979840,"startTime":"0","endTime":"0","summary":"石药集团与Elevation Oncology合作的Claudin 18.2抗体偶联药物EO-3021因临床试验数据不佳，全球开发计划被终止。该药物曾被视为潜力巨大，为石药带来超10亿美元交易，但疗效缺乏竞争力，尤其在美国低表达患者中效果不佳，引发研发人士对药物设计的质疑。同时，Claudin 18.2 ADC药物普遍缺乏长期安全性数据，未来发展仍面临未知与风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032701212894c1d81d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032701212894c1d81d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ELEV","BK4139","ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2522853130","title":"石药集团ADC创新药出海两年多被退货，数据造假还是被造谣","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853130","media":"南方都市报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853130?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 08:12","pubTimestamp":1742947947,"startTime":"0","endTime":"0","summary":"“石药集团数据做假，高价卖给老外的药失败了，拖累整个医药板块。”上周五（3月21日），港股生物医药板块呈现显著回调趋势。尽管有机构分析人士认为，当天市场波动与短期资金获利回吐有关，但网络上还是传出类似上面那样的非理性声音。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503263356136356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1152091754.HKD","SG9999004220.SGD","BK1574","LU1008478684.HKD","IE0008369823.USD","BK1515","LU1226287875.USD","BK4080","LU1152091168.USD","01093","IE00BZ08YR35.GBP","IE00B5MMRT66.SGD","LU1226287792.SGD","06978","LU0501845795.SGD","LU0067412154.USD","ADC","IE00B031HY20.USD","LU0140636845.USD","BK4231","LU1951186391.HKD","IE0008368742.USD","BK1191","IE00BZ08YS42.EUR","BK1521","LU1960683339.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226288253.USD","IE00BZ08YT58.USD","LU1807302812.USD","LU0326950275.SGD","LU0880133367.SGD","BK1161","LU1226287529.USD","IE00B543WZ88.USD","LU1993786604.SGD"],"gpt_icon":0},{"id":"2522027589","title":"药明生物2024年业绩稳健攀升， 2025年预期加速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2522027589","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522027589?lang=zh_cn&edition=fundamental","pubTime":"2025-03-25 18:37","pubTimestamp":1742899020,"startTime":"0","endTime":"0","summary":"EBITDA和EBITDA利润率：截至2024年底，EBITDA同比增长16.7%至人民币65.5亿元。自2018年以来，集团总计赢得89个综合项目。生产业务2024年，集团服务了66个临床Ⅲ期项目和21个非新冠商业化生产项目，完成了16个PPQ项目，并计划在2025年完成24个PPQ项目。未完成订单截至2024年12月31日，集团未完成订单总额达185亿美元，其中未完成服务订单和未完成潜在里程碑付款订单分别为105亿美元和80亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4649172_ZH49172_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0949170772.SGD","BK4080","LU0181495838.USD","LU1242518857.USD","LU0572944931.SGD","LU0516423091.SGD","LU0256863811.USD","LU0051755006.USD","LU0516422952.EUR","SG9999002463.SGD","ICE","BK4585","BK1576","SG9999004303.SGD","WXXWY","BK4231","LU1201861249.SGD","IE00BQXX3D17.EUR","LU0689626769.HKD","LU0140636845.USD","ADC","02269","LU0661504455.SGD","LU0348735423.USD","GB00BDT5M118.USD","BK4112","LU0052750758.USD","LU2237957811.SGD","LU0043850808.USD","LU0130517989.USD","LU0456827905.SGD","LU0819121731.USD","LU0359201612.USD","LU0359202008.SGD","LU0390134368.USD","LU0124676726.USD","BK1589","SG9999002562.SGD","LU0327786744.USD","LU0307460666.USD","IE00BQXX3C00.GBP","LU0154236417.USD","LU0823426480.USD","LU0980610538.SGD","BK4121","LU0708995583.HKD","LU0154245673.USD","BK1610","LU0516422366.SGD"],"gpt_icon":1},{"id":"2522092955","title":"艾伯维起诉Genmab及普方生物等主体","url":"https://stock-news.laohu8.com/highlight/detail?id=2522092955","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522092955?lang=zh_cn&edition=fundamental","pubTime":"2025-03-25 09:44","pubTimestamp":1742867089,"startTime":"0","endTime":"0","summary":"艾伯维要求法院判处损害赔偿并颁布禁令，阻止Genmab继续使用该技术。Genmab已公告将全力应诉，并计划继续推进Rina-S的临床试验及商业化准备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250325154303a6a3101c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250325154303a6a3101c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965509283.SGD","BK4533","LU1093756168.USD","ABBV","BK4231","BK4581","LU1496350502.SGD","LU0661504455.SGD","IE00BJT1NW94.SGD","IE00BVYPNW00.USD","LU1496350171.SGD","LU2237443549.SGD","IE00B19Z3B42.SGD","LU1037948541.HKD","LU1732799900.SGD","LU2468319806.SGD","SG9999001440.SGD","IE0004445239.USD","LU1585245621.USD","LU2112291526.USD","BK4550","LU1989772840.SGD","LU1093756325.SGD","LU2129689605.HKD","LU2237443465.HKD","LU0211328371.USD","IE00B3PB1722.GBP","LU2089283258.USD","LU0943347566.SGD","SG9999015945.SGD","SG9999003800.SGD","IE00B42XCP33.USD","LU1551013342.USD","LU0198837287.USD","LU2089284900.SGD","SG9999015978.USD","LU2133065610.SGD","SG9999015986.USD","IE0009355771.USD","LU0738911758.USD","LU2347655156.SGD","LU1934455863.HKD","ADC","LU1989772923.USD","BK4534","BK4566","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0965509010.AUD","LU0128525929.USD"],"gpt_icon":0},{"id":"2521771062","title":"药明合联2024年再创辉煌：业务强劲增长，财务业绩亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2521771062","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521771062?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 22:33","pubTimestamp":1742826780,"startTime":"0","endTime":"0","summary":"\" 财务亮点 - 营业收入：截至2024年12月31日，本集团收入同比增长90.8%，至人民币40.52亿元。2024年集团净利率达26.4%，较2023年提升13.0个百分点。截至报告期末，药明合联赋能客户实现对外授权的资产均处于积极开发状态。凭借平台化优势，集团在2024年持续赋能客户，并成为协助客户取得IND获批数量全球最多的ADC CRDMO，以持续巩固行业领导地位。为应对快速增长的市场需求，集团宣布计划在无锡基地新增两条制剂生产线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4648117_ZH48117_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["SG9999014674.SGD","BK4231","BK4189","ESG","ADC","LU2308191902.HKD","LU2211817866.USD","LU1721429402.USD","02268","DAR","LU2380233275.USD","BK1141","LU2488822045.USD","LU0256331488.USD","LU1721429741.USD","BK4080"],"gpt_icon":1},{"id":"2521725952","title":"ADC CRDMO龙头药明合联(02268)业绩“封神”：营收破40亿！暴涨90.8% 净利狂飙277%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521725952","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521725952?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 20:31","pubTimestamp":1742819460,"startTime":"0","endTime":"0","summary":"本次的全年业绩公告中，药明合联2024年全年营业收入达40.52亿元人民币，同比增长90.8%;毛利润达12.40亿元人民币，增速高达121.6%，毛利率从2023年的26.3%跃升至30.6%，盈利能力显著提升;净利润更是同比激增277%至10.70亿元，净利润率从13.4%提升至26.4%。财报显示，截至报告期，药明合联全球客户总数扩大到499家，2024年新增154家客户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["ADC","02268"],"gpt_icon":0},{"id":"2521911737","title":"【券商聚焦】中信证券：PD-L1 ADC药物兼具双重功效 潜在市场规模巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2521911737","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521911737?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 10:49","pubTimestamp":1742784588,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券指出，PD-L1 ADC药物兼具免疫治疗药物和靶向ADC的双重功效，潜在可触及市场规模有望对标全球超过500亿美元的免疫治疗药物。多个美国市场高发的癌种PD-L1阳性率超过50%。辉瑞公司的PD-L1 ADC已经在NSCLC、HNSCC重度经治人群展现出优异疗效，并且安全性可控，辉瑞预计将在25H2启动2项三期临床，为赛道大幅增加研发确定性。国内复宏汉霖(02696)的PD-L1 ADC已经在2025年前后陆续启动5项二期临床，并且预计其有望在2025年读出一期临床数据。综上，建议关注PD-L1 ADC的临床潜力和商业化价值。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/YTg5NTFiOTlmZmEyYmE3ODE4NjgwNzc4MTUzMTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/YTg5NTFiOTlmZmEyYmE3ODE4NjgwNzc4MTUzMTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955720","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","LU1169590202.USD","LU1997245094.SGD","BK1521","BK1564","BK1516","BK0183","LU2289578879.USD","02157","06030","BK1161","BK0196","BK0188","BK0012","LU1794554557.SGD","LU0405327148.USD","LU1720050803.USD","BK0028","LU1997244956.HKD","LU1997245177.USD","LU2495084118.USD","09966","600030","LU1064130708.USD","PD","LU1064131003.USD","LU1169589451.USD","BK1574","BK1147","LU2148510915.USD","BK4080","BK4231","02696","LU0405327494.USD","BK4023","ADC","BK0276"],"gpt_icon":0},{"id":"2521771068","title":"信达生物IBI354 (创新型HER2 ADC) 治疗铂耐药卵巢癌的III期临床研究完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2521771068","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521771068?lang=zh_cn&edition=fundamental","pubTime":"2025-03-24 08:00","pubTimestamp":1742774400,"startTime":"0","endTime":"0","summary":"同时，IBI354治疗展现出明显优于其它ADC的优秀临床安全性和治疗耐受性。\" 信达生物制药集团高级副总裁周辉博士表示：\"很高兴IBI354在HER2表达的铂耐药卵巢癌的临床III期研究完成首例受试者首次给药，也十分期待IBI354获得积极结果，为HER2表达的铂耐药卵巢癌患者提供更理想的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4647606_ZH47606_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1969619763.USD","BK4231","IVBIY","ADC","01801","BK4134","III","BK1583","BK1589","BK4139","BK1161","BK4080","LU2488822045.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2521663267","title":"【中信证券：PD-L1 ADC药物有望触及全球超500亿美元IO市场】中信证券指出，PD-L1 ADC药物兼具免疫治疗药物和靶向ADC的双重功效，潜在可触及市场规模有望对标全球超过500亿美元的免疫治疗药物。多个美国市场高发的癌种PD-L1阳性率超过50%。辉瑞公司的PD-L1 ADC已经在NSCLC、HNSCC重度经治人群展现出优异疗效，并且安全性可控，辉瑞预计将在25H2启动2项三期临床，为赛道大幅增加研发确定性。国内复宏汉霖的PD-L1 ADC已经在2025年前后陆续启动5项二期临床，并且预计其有望在2025年读出一期临床数据。综上，建议关注PD-L1 ADC的临床潜力和商业化价值。","url":"https://stock-news.laohu8.com/highlight/detail?id=2521663267","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521663267?lang=zh_cn&edition=fundamental","pubTime":"2025-03-22 09:18","pubTimestamp":1742606298,"startTime":"0","endTime":"0","summary":"中信证券指出，PD-L1 ADC药物兼具免疫治疗药物和靶向ADC的双重功效，潜在可触及市场规模有望对标全球超过500亿美元的免疫治疗药物。多个美国市场高发的癌种PD-L1阳性率超过50%。辉瑞公司的PD-L1 ADC已经在NSCLC、HNSCC重度经治人群展现出优异疗效，并且安全性可控，辉瑞预计将在25H2启动2项三期临床，为赛道大幅增加研发确定性。国内复宏汉霖的PD-L1 ADC已经在2025年前后陆续启动5项二期临床，并且预计其有望在2025年读出一期临床数据。综上，建议关注PD-L1 ADC的临床潜力和商业化价值。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/22091848957154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0306807586.USD","LU0225284248.USD","BK4592","BK4080","LU1023059063.AUD","BK0276","LU0289739699.SGD","LU0321505868.SGD","LU1328615791.USD","SG9999011175.SGD","LU1066051498.USD","LU2289578879.USD","LU0122379950.USD","IE000M9KFDE8.USD","BK0188","BK1161","600030","LU0306806265.USD","BK4581","LU0985481810.HKD","02696","PD","SG9999002232.USD","LU1169589451.USD","IE00B19Z3581.USD","LU1997245177.USD","LU2148510915.USD","BK4588","SG9999001176.SGD","LU1169590202.USD","BK0183","IE0002270589.USD","LU0321505439.SGD","LU0170899867.USD","BK4568","IE00BLSP4239.USD","BK4550","LU1997245094.SGD","IE00B19Z3B42.SGD","LU1997244956.HKD","BK4533","BK4007","IE00BBT3K403.USD","LU1066053197.SGD","SG9999013999.USD","ADC","BK0012","LU0868494617.USD","06030"],"gpt_icon":0},{"id":"2521236062","title":"吉利德ADC单抗乳腺癌新适应症在中国获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2521236062","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521236062?lang=zh_cn&edition=fundamental","pubTime":"2025-03-21 23:18","pubTimestamp":1742570332,"startTime":"0","endTime":"0","summary":"3月21日，吉利德科学宣布，拓达维（英文商品名Trodelvy，戈沙妥珠单抗）获得中国国家药品监督管理局批准，用于治疗既往接受过内分泌治疗且在转移性疾病阶段接受过至少二种其他系统性治疗的不可切除局部晚期或转移性的激素受体（HR）阳性、人类表皮生长因子受体2（HER2）阴性（IHC0、IHC1+或IHC2+/ISH-）乳腺癌成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503213352838514.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503213352838514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"2520089096","title":"智元机器人提出一种全新的数据采集范式ADC 与传统范式相比，使用20%数据量达到其2.7倍的效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2520089096","media":"视频滚动新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520089096?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 21:36","pubTimestamp":1742304960,"startTime":"0","endTime":"0","summary":"智元机器人进一步提出一种全新的数据采集范式ADC （Adversarial Data Collection,对抗数据采集），大幅提升了数据的信息密度和多样性，降低了后训练所需的数据量、压缩了训练成本，且提升了模型的鲁棒性和泛化性，与传统范式相比，使用20%数据量达到其2.7倍的效果。ADC 技术以数据高信息密度与多样性为核心，重新定义了具身智能的数据采集方式。通过GO-1 × ADC的新范式，大幅降低了具身智能的落地门槛，赋能千行百业。（智元机器人）\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/videoroll/2025-03-18/doc-ineqautf2394160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2520653993","title":"港股异动 | 康宁杰瑞制药-B(09966)涨超19% HER2双抗ADC药物JSKN003获突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2520653993","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520653993?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 10:06","pubTimestamp":1742263572,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康宁杰瑞制药-B涨超19%，截至发稿，涨19.07%，报6.93港元，成交额2158.06万港元。消息面上，康宁杰瑞生物制药与石药集团今早共同宣布，HER2双特异性抗体偶联药物JSKN003获得国家药品监督管理局药品审评中心突破性疗法认定，用于治疗铂耐药复发性上皮性卵巢癌、原发性腹膜癌或输卵管癌，且不限HER2表达水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1263212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK4231","ADC","BK1574","BK1161","BK4080"],"gpt_icon":0},{"id":"2520007661","title":"康宁杰瑞HER2双抗ADC药物JSKN003获突破性疗法认定，用于治疗铂耐药卵巢癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2520007661","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520007661?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 09:38","pubTimestamp":1742261880,"startTime":"0","endTime":"0","summary":"苏州2025年3月18日 /美通社/ -- 康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体偶联药物JSKN003获得国家药品监督管理局药品审评中心突破性疗法认定，用于治疗铂耐药复发性上皮性卵巢癌、原发性腹膜癌或输卵管癌，且不限HER2表达水平。JSKN003在该适应症的Ⅲ期临床研究处于入组阶段，目前正在顺利进行中。此次获得突破性疗法认定，有望加快JSKN003的临床开发和审评审批速度，早日使更多铂耐药卵巢癌患者获益。康宁杰瑞保留JSKN003的独家生产权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4643471_ZH43471_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4080","IE00BFMHRM44.USD","GLW","LU0348723411.USD","BK4512","BK4588","BK4585","09966","BK1161","BK4148","BK1574","ADC","BK4231"],"gpt_icon":0},{"id":"2520688563","title":"FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520688563","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520688563?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 04:05","pubTimestamp":1742241900,"startTime":"0","endTime":"0","summary":"Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 million Transaction expected to close by mid-2025  Upon close of sale of FibroGen China, cash runway ext","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/17/3044083/33525/en/FibroGen-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0314104364.USD","IE00BKVL7J92.USD","LU2236285917.USD","LU2347655156.SGD","LU0158827781.USD","LU1162221912.USD","BK4588","BK4109","LU0320765646.SGD","BK4162","LU0912757837.SGD","LU0128525689.USD","LU0098860793.USD","DD","BK4505","LU1548497426.USD","LU0310799852.SGD","BK4516","LU1267930227.SGD","LU0795875086.SGD","LU1668664300.SGD","BK4534","LU0106831901.USD","LU2023251221.USD","LU0225283273.USD","CIA","FGEN","LU0211328371.USD","LU0971096721.USD","BK4127","LU0006306889.USD","BK4504","BK4080","ADC","LU0052756011.USD","LU1363072403.SGD","BK4581","LU2133065610.SGD","LU2357305700.SGD","LU1720051017.SGD","LU0211327993.USD","LU1732799900.SGD","LU1732800096.USD","LU2271345857.HKD","LU2089284900.SGD","PET","LU2028103732.USD","LU1720051108.HKD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2520055536","title":"东曜药业(01875.HK)：ADC赛道出海破局者，国际质量体系能否打开利润增长极?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520055536","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520055536?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 08:58","pubTimestamp":1742173085,"startTime":"0","endTime":"0","summary":"当市场将CDMO行业的估值锚定在规模与盈利层面时，东曜药业正在搭建一条鲜为人知的“隐秘价值成长曲线”——以打造国际领先的产能和质量管理体系构建全球商业化能力，收获更多的业务发展机遇。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1903886","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1574","BK4231","ADC","BK1161","01875","BK4080"],"gpt_icon":0},{"id":"2519315266","title":"成都普诺科技取得一种 ADC 电路板测量辅助冶具专利，便于将多种大小电路板辅助安装且提高效率","url":"https://stock-news.laohu8.com/highlight/detail?id=2519315266","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519315266?lang=zh_cn&edition=fundamental","pubTime":"2025-03-15 20:42","pubTimestamp":1742042550,"startTime":"0","endTime":"0","summary":"金融界 2025 年 3 月 15 日消息，国家知识产权局信息显示，成都普诺科技有限公司取得一项名为“一种 ADC 电路板测量辅助冶具”的专利，授权公告号 CN 222612227 U，申请日期为 2024 年 4 月。通过天眼查大数据分析，成都普诺科技有限公司共对外投资了1家企业，参与招投标项目3次，财产线索方面有商标信息1条，专利信息90条，此外企业还拥有行政许可2个。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/15204248778357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2519781312","title":"港股异动 | 药明合联(02268)盘中涨超8% 宣布与AbTis签署战略合作意向书 加速创新型ADC药物研发推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2519781312","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519781312?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 10:04","pubTimestamp":1741917862,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明合联盘中涨超8%，截至发稿，涨8.13%，报37.9港元，成交额7110.95万港元。消息面上，3月11日，药明合联宣布与韩国生物技术公司AbTis签署战略合作意向书。根据协议，药明合联将纳入AbTis的先进定点偶联技术平台AbClick。药明合联将依托其广泛的全球客户网络，全力推动AbTis技术的广泛应用，助力双方在生物偶联药领域的深度合作与共赢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1261792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","02268","BK1141","ADC","BK4231","SG9999014674.SGD","BK4080"],"gpt_icon":0},{"id":"2519288964","title":"石药集团：SYH2051获美国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2519288964","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519288964?lang=zh_cn&edition=fundamental","pubTime":"2025-03-13 18:06","pubTimestamp":1741860392,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1152091168.USD","BK7095","IE00BZ08YT58.USD","LU1152091754.HKD","LU0072913022.USD","03347","IE00B5MMRT66.SGD","SG9999004220.SGD","BK1191","LU1993786604.SGD","LU1951186391.HKD","BK1583","IE00B543WZ88.USD","LU1226287792.SGD","LU1807302812.USD","LU1226288253.USD","BK1521","LU1960683339.HKD","BK1576","LU1226287875.USD","BK4231","IE00B031HY20.USD","BK4109","LU0880133367.SGD","IE0008368742.USD","LU1226287529.USD","BK1141","ADC.AU","IE0008369823.USD","LU0067412154.USD","BK1515","01093","IE00BZ08YS42.EUR","LU0140636845.USD","LU1008478684.HKD","ADC","LU1226288170.HKD","IE00BZ08YR35.GBP","LU0326950275.SGD","BK4139","LU0501845795.SGD","BK4080","DNA"],"gpt_icon":0},{"id":"2519858164","title":"药明合联荣膺2025“亚太生物医药卓越奖”多项殊荣","url":"https://stock-news.laohu8.com/highlight/detail?id=2519858164","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519858164?lang=zh_cn&edition=fundamental","pubTime":"2025-03-13 13:59","pubTimestamp":1741845540,"startTime":"0","endTime":"0","summary":"上海2025年3月13日 /美通社/ -- 全球领先的专注于提供抗体偶联药物等生物偶联药物端到端CRDMO服务的药明合联，今日宣布公司在“2025亚太生物制药卓越奖”中荣获四项大奖。“亚太生物制药卓越奖”旨在评选出每年在生物医药行业表现卓越的企业。\" 本次获奖延续了药明合联在“2024 World ADC Awards”中荣获\"Best CDMO Winner\"的卓越表现，进一步肯定了公司的行业领军地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4640448_ZH40448_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["SG9999014674.SGD","BK4231","ADC","02268","BK1141","LU2488822045.USD","BK4080"],"gpt_icon":0},{"id":"2519076506","title":"科伦博泰生物-B盘中涨超5% TROP2 ADC芦康沙妥珠单抗第二项适应症获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2519076506","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519076506?lang=zh_cn&edition=fundamental","pubTime":"2025-03-13 11:40","pubTimestamp":1741837200,"startTime":"0","endTime":"0","summary":"　　科伦博泰生物-B盘中涨超5%，截至发稿，股价上涨3.24%，现报242港元，成交额9741.92万港元。　　科伦博泰生物近日公布，公司靶向人滋养细胞表面抗原2的抗体药物偶联物芦康沙妥珠单抗（佳泰莱）获国家药品监督管理局批准第二个适应症，用于治疗经表皮生长因子受体酪氨酸激酶抑制剂和含铂化疗治疗后进展的EGFR基因突变阳性的局部晚期或转移性非鳞状非小细胞肺癌成人患者。这是全球首个在肺癌适应症获批上市的TROP2ADC药物。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-13/doc-inepnpwr0866652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4080","BK4231","06990","LU0196878994.USD","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2025-05-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-13"},{"date":"2025-04-30","symbol":"ADC","amount":0.256,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-30","defaultRemindTime":1746019800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-04-30","currency":"USD","dateTimestamp":1745985600000,"payDate":"2025-05-14"},{"market":"US","date":"2025-04-22","symbol":"ADC","fiscalQuarterEnding":"2025/03","expectedEps":1.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1745294400000,"reportTimeType":"post","actualEps":1.06},{"date":"2025-03-31","symbol":"ADC","amount":0.253,"announcedDate":"2025-03-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-14","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-14"},{"date":"2025-02-28","symbol":"ADC","amount":0.253,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-28","defaultRemindTime":1740753000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-14","payableDate":"2025-02-28","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-14","value":0.465,"currency":"USD"},{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-13","value":0.465,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2016-01-05","value":0.465,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":21,"updateTime":1746676800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2025-05-22","current":43.002313,"percent":0.679414,"low":31.539495,"twenty":37.571542,"median":40.653059,"eighty":44.677947,"high":53.261716,"avg":41.113443,"sd":4.473729,"marketCap":8227804641},"quantilePoints":[{"date":"2020-05-29","current":40.87144,"twenty":30.127131,"median":35.446997,"eighty":42.650816,"marketCap":3390817259},{"date":"2020-06-05","current":44.67404,"twenty":30.209273,"median":35.585113,"eighty":42.788104,"marketCap":3706292371},{"date":"2020-06-12","current":43.306667,"twenty":30.259415,"median":35.631973,"eighty":42.882133,"marketCap":3592850978},{"date":"2020-06-19","current":43.938263,"twenty":30.399208,"median":35.674606,"eighty":42.926676,"marketCap":3645250098},{"date":"2020-06-26","current":40.969109,"twenty":30.470777,"median":35.744304,"eighty":42.989446,"marketCap":3398920216},{"date":"2020-07-02","current":43.619209,"twenty":30.497525,"median":35.833506,"eighty":43.024146,"marketCap":3618780439},{"date":"2020-07-10","current":41.587683,"twenty":30.543737,"median":35.93098,"eighty":43.037844,"marketCap":3450238941},{"date":"2020-07-17","current":42.77274,"twenty":30.603622,"median":36.099734,"eighty":43.037844,"marketCap":3548554815},{"date":"2020-07-24","current":37.537078,"twenty":30.71291,"median":36.149452,"eighty":43.037844,"marketCap":3365424257},{"date":"2020-07-31","current":40.350852,"twenty":30.745133,"median":36.199495,"eighty":43.037844,"marketCap":3617696027},{"date":"2020-08-07","current":41.351038,"twenty":30.776927,"median":36.250246,"eighty":43.037844,"marketCap":3707368648},{"date":"2020-08-14","current":40.224323,"twenty":30.922362,"median":36.348523,"eighty":43.037844,"marketCap":3606351900},{"date":"2020-08-21","current":40.308676,"twenty":31.08368,"median":36.544296,"eighty":43.037844,"marketCap":3613914651},{"date":"2020-08-28","current":40.628012,"twenty":31.203975,"median":36.640352,"eighty":43.037844,"marketCap":3642545066},{"date":"2020-09-04","current":40.013441,"twenty":31.296906,"median":36.781594,"eighty":43.037844,"marketCap":3587445022},{"date":"2020-09-11","current":40.079718,"twenty":31.383772,"median":36.974643,"eighty":43.037844,"marketCap":3593387184},{"date":"2020-09-18","current":38.59149,"twenty":31.509762,"median":37.052903,"eighty":43.037844,"marketCap":3459958646},{"date":"2020-09-25","current":37.645532,"twenty":31.534039,"median":37.273263,"eighty":43.037844,"marketCap":3375147794},{"date":"2020-10-02","current":39.29644,"twenty":31.704694,"median":37.362034,"eighty":43.037844,"marketCap":3523161638},{"date":"2020-10-09","current":40.368928,"twenty":31.803276,"median":37.497873,"eighty":43.037844,"marketCap":3619316617},{"date":"2020-10-16","current":39.386818,"twenty":31.867808,"median":37.57347,"eighty":43.037844,"marketCap":3531264585},{"date":"2020-10-23","current":40.224079,"twenty":31.975443,"median":37.612137,"eighty":43.037844,"marketCap":3633239960},{"date":"2020-10-30","current":38.164301,"twenty":31.975443,"median":37.733323,"eighty":43.037844,"marketCap":3447190528},{"date":"2020-11-06","current":38.797606,"twenty":31.975443,"median":37.935059,"eighty":43.037844,"marketCap":3504393786},{"date":"2020-11-13","current":41.26934,"twenty":31.975443,"median":38.046028,"eighty":43.037844,"marketCap":3727653105},{"date":"2020-11-20","current":40.039622,"twenty":31.975443,"median":38.167733,"eighty":43.037844,"marketCap":3616578817},{"date":"2020-11-27","current":40.506914,"twenty":31.975443,"median":38.310136,"eighty":43.037844,"marketCap":3658787046},{"date":"2020-12-04","current":40.580698,"twenty":31.975443,"median":38.471704,"eighty":43.037844,"marketCap":3665451504},{"date":"2020-12-11","current":40.230228,"twenty":31.975443,"median":38.545534,"eighty":43.037844,"marketCap":3633795331},{"date":"2020-12-18","current":39.344831,"twenty":31.975443,"median":38.676992,"eighty":43.037844,"marketCap":3553821844},{"date":"2020-12-24","current":39.762935,"twenty":31.975443,"median":38.782235,"eighty":43.037844,"marketCap":3591587102},{"date":"2020-12-31","current":40.937316,"twenty":31.975443,"median":38.892751,"eighty":43.037844,"marketCap":3697663047},{"date":"2021-01-08","current":45.450661,"twenty":31.975443,"median":39.008592,"eighty":43.047885,"marketCap":4105330986},{"date":"2021-01-15","current":44.653159,"twenty":31.975443,"median":39.245492,"eighty":43.22631,"marketCap":4033296550},{"date":"2021-01-22","current":45.359718,"twenty":31.975443,"median":39.341757,"eighty":43.313411,"marketCap":4097116533},{"date":"2021-01-29","current":44.212433,"twenty":31.975443,"median":39.41667,"eighty":43.4163,"marketCap":3993488046},{"date":"2021-02-05","current":46.262155,"twenty":31.975443,"median":39.41667,"eighty":43.554978,"marketCap":4178629185},{"date":"2021-02-12","current":45.520618,"twenty":31.975443,"median":39.41667,"eighty":43.618647,"marketCap":4111649797},{"date":"2021-02-19","current":43.859591,"twenty":31.975443,"median":39.41667,"eighty":43.642628,"marketCap":4007933303},{"date":"2021-02-26","current":44.718497,"twenty":31.977009,"median":39.430911,"eighty":43.756513,"marketCap":4086420942},{"date":"2021-03-05","current":44.656157,"twenty":31.975443,"median":39.41667,"eighty":43.796506,"marketCap":4080724259},{"date":"2021-03-12","current":46.594043,"twenty":31.975443,"median":39.41667,"eighty":43.856021,"marketCap":4257810284},{"date":"2021-03-19","current":46.240217,"twenty":31.975443,"median":39.41667,"eighty":43.889974,"marketCap":4225477299},{"date":"2021-03-26","current":46.69811,"twenty":31.977009,"median":39.430911,"eighty":43.995818,"marketCap":4267319985},{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-22","current":43.002313,"twenty":37.571542,"median":40.653059,"eighty":44.677947,"marketCap":8227804641}],"updateTime":1748005519968}}}